Purchases are not available yet. You can browse the site and sign in.
The 1971 UN Convention and Psilocybin Explained · Microdosing College
Law
The 1971 UN Convention and Psilocybin: Why It's Banned Almost Everywhere
By Microdosing College Editorial·Last updated November 18, 2026·7 min read
The 1971 Convention on Psychotropic Substances is the international treaty that explains why psilocybin is a Schedule I controlled substance in most of the world. Understanding how that treaty was drafted — and, critically, what it left out — is essential context for anyone trying to make sense of the patchwork of national laws around psilocybin mushrooms and truffles. This article is a companion to our full microdosing laws by country overview.
What the 1971 Convention actually says
The Convention on Psychotropic Substances was adopted in Vienna on 21 February 1971, under the auspices of the United Nations. It entered into force on 16 August 1976 and now has 184 state parties — making it one of the most widely ratified drug-control treaties in existence. Its core mechanism is a four-schedule system: substances in Schedule I carry the strictest controls, including a near-total ban on production, trade, and possession except for very narrowly defined scientific or medical purposes.
Psilocybin (the prodrug) and psilocin (the active metabolite) were both placed in Schedule I of the 1971 Convention at the time of adoption (INCB, Convention on Psychotropic Substances 1971, Schedule I). Article 7 of the treaty requires parties to prohibit all uses of Schedule I substances except for scientific research and very limited medical uses authorised by the competent national authority. In practice, that language translated into blanket domestic prohibition in almost every signatory state.
The key provision for domestic law is Article 3(1), which requires parties to apply the treaty's controls to "any preparation" of a Schedule I substance. On paper, that would seem to capture mushrooms and truffles containing psilocybin or psilocin.
The commentary gap that changed everything
The drafting history tells a more complicated story. The official INCB commentary on the 1971 Convention — a document published by the International Narcotics Control Board to guide interpretation — addressed the question of plants containing scheduled substances directly. It concluded that preparations made from plants containing psychotropic substances are not under international control unless the substance has been isolated in pure or concentrated form.
The relevant passage, widely cited in legal analysis, states that fungi (mushrooms and truffles) containing psilocybin and psilocin are not themselves listed in the schedules and that parties are not formally obligated under the treaty to control them as such. This is not a loophole in the colloquial sense — it was an intentional drafting choice, reflecting the negotiating position that international control of every plant or fungus that happens to contain a scheduled molecule would be practically unworkable and would interfere with traditional and cultural uses.
The practical consequence is that the 1971 Convention controls the isolated chemical compounds psilocybin and psilocin, but leaves it to individual national legislatures to decide whether to extend that control to fresh or dried mushrooms, truffles (sclerotia), spores, or mycelium. Some countries extended the ban by explicit legislation. Others — including the Netherlands — did not, creating the legal spaces still in operation today.
How signatory states responded: the divergence
The divergence among signatories is striking and directly traceable to how each country chose to implement the convention at the national level.
Countries that extended control explicitly: The United Kingdom provides a clear example. When the Misuse of Drugs Act 1971 was passed, psilocybin and psilocin were classified as Class A controlled substances — but mushrooms were initially in a grey area because their legal status depended on whether they had been "prepared." Fresh mushrooms picked from the ground were arguably uncontrolled. Parliament ended that ambiguity with Section 21 of the Drugs Act 2005 (UK legislation.gov.uk), which expressly added any fungus containing psilocin or psilocybin to Class A regardless of preparation — closing the gap by name. Fresh mushrooms, dried mushrooms, truffles, and spores are all now Class A in the UK.
The Netherlands: a gap left open. The Dutch Opium Act (Opiumwet) implemented the 1971 Convention by listing psilocybin and psilocin as List I substances (roughly equivalent to Schedule I). When pressure to also ban mushrooms grew in the early 2000s, the government added approximately 188 named mushroom species to List II of the Opium Act — a softer classification — effective 1 December 2008. Crucially, the legislation was drafted to cover paddo's (mushrooms, the above-ground fruiting body) but not truffles (sclerotia), the underground storage organ that looks and functions differently. Because truffles were never added to either list, they remain legal to sell, purchase, and possess in the Netherlands. That is the precise legal basis explored in our is microdosing legal in the Netherlands guide.
Other European states generally tightened controls through their domestic drug laws and did not leave comparable gaps open. The European Union Drugs Agency (EUDA) maintains an authoritative drug profile for hallucinogenic mushrooms tracking how member states have extended controls beyond the 1971 Convention's minimum requirements (EUDA, Hallucinogenic mushrooms drug profile). Germany, France, and Spain, for example, have all brought mushrooms and relevant fungal preparations within their domestic controlled-substance frameworks. For a side-by-side comparison see our microdosing laws in Europe compared article.
Why Schedule I? The science-policy tension
Schedule I under the 1971 Convention is reserved for substances with a "high potential for abuse" that constitute a "particularly serious risk to public health" and have "very limited or no therapeutic usefulness" — the most restrictive category. Psilocybin and psilocin were placed there in 1971 alongside substances such as LSD and mescaline, largely on the basis of their strong psychoactive effects and concerns arising from the counterculture movements of the 1960s rather than extensive clinical evidence.
Decades later, that scheduling decision sits in uncomfortable tension with a body of clinical research conducted under special governmental authorisations (precisely the narrow research exemptions the treaty allows). Regulatory bodies in Australia and several other jurisdictions have, in recent years, taken steps to permit medically supervised use of psilocybin within their domestic frameworks — without withdrawing from the 1971 Convention. Those developments are outside the scope of this article but are covered in our broader microdosing laws by country overview and in our research library.
The scheduling itself has not changed. Any country that is party to the 1971 Convention remains bound by Article 7's prohibitions on psilocybin and psilocin as isolated substances. What countries can vary — and what they have varied significantly — is the scope of domestic legislation covering the fungi that produce those compounds.
What this means practically
For anyone trying to understand why psilocybin laws differ so sharply between neighbouring countries, the 1971 Convention and its commentary gap is the starting point. The treaty explains the near-universal prohibition on pure psilocybin and psilocin. The gap in the INCB commentary explains why mushrooms and truffles are not uniformly controlled. And each country's domestic legislative response to that gap explains the patchwork you see today — from the Netherlands' legal truffle market to the UK's blanket Class A ban on any fungus containing psilocin.
If you are considering any form of psilocybin use, understanding the law in your jurisdiction is a prerequisite, not an afterthought. Use our microdosing laws by country guide as your starting map, and always check current local legislation directly — treaty interpretation and domestic law can shift. If you are also considering whether psilocybin is appropriate for your health situation, the screener is the right first step before any other decision.
Frequently asked
Does the 1971 Convention ban psilocybin mushrooms directly?+
No. The treaty places the isolated compounds psilocybin and psilocin in Schedule I, but the official INCB commentary states that preparations of plants or fungi containing those substances are not themselves under international control. Whether mushrooms or truffles are banned depends on each country's domestic legislation.
Why are psilocybin truffles legal in the Netherlands if the 1971 Convention bans psilocybin?+
The Netherlands implemented the 1971 Convention by listing psilocybin and psilocin as controlled substances and, in 2008, added named mushroom species to the Opium Act. Truffles (sclerotia) were never added to either list and remain legal to sell and purchase within the Netherlands.
What is Schedule I under the 1971 Convention?+
Schedule I is the most restrictive category in the 1971 Convention on Psychotropic Substances. It covers substances deemed to have a high potential for abuse, a serious public-health risk, and limited or no accepted therapeutic use. Parties are required to prohibit all uses except narrowly authorised scientific research.
Can a country allow medical psilocybin therapy while still being a party to the 1971 Convention?+
Yes, within limits. Article 7 of the convention allows parties to permit use of Schedule I substances for scientific research and very limited medical purposes authorised by national competent authorities. Countries such as Australia have used this provision to permit supervised therapeutic use under strict regulatory frameworks, without withdrawing from the treaty.
How did the UK close the mushroom loophole that existed in other countries?+
Section 21 of the Drugs Act 2005 explicitly added any fungus containing psilocin or psilocybin to Class A of the Misuse of Drugs Act 1971, regardless of whether it had been prepared or processed. This directly closed the ambiguity that existed before and that some other countries still have not resolved in their own law.
This guide is general educational information about microdosing, not medical advice and not a recommendation to use any substance. It can't account for your personal health. If you take medication or live with a mental-health condition, speak with a qualified professional before making any decision.